Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...
BOSTON, MA, UNITED STATES, February 13, 2025 /EINPresswire / -- When Ruihua Liu founded Hill Research, the goal was clear: to revolutionize clinical trials using Generative AI. With a background in ...
Sanofi is tapping San Francisco-based Atomwise for a new AI-fuelled drug discovery deal ... including Merck & Co, Eli Lilly, and AbbVie. In 2019 they struck a major deal with China's Hansoh ...
They also discovered that cigarette use declined among a subgroup of smokers in the study, lending weight to the hypothesis ...
According to Statifacts, the global clinical trials market size is calculated at USD 126.30 billion in 2025 and is expected ...
Former DeepMind employees raise $40 million to launch London-based startup 'laser-focused' on AI protein design.
Boehringer will leverage ExpressionEdits' Genetic Syntax Engine which generates optimized introns to increase protein expression.
As the demand for novel therapies and personalized medicine surges, leaders are uniquely positioned to create a culture of creativity, collaboration and innovation.